Cargando…

Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study

This study aimed to optimize the preparation conditions of pachyman (PHY)-loaded poly(d,l-lactic acid) (PLA) (PHYP) nanospheres by response surface methodology, explore their characteristics, and assess their effects on splenic lymphocytes. Double emulsion solvent evaporation was used to synthesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Sisi, Luo, Li, Bo, Ruonan, Liu, Zhenguang, Xing, Jie, Niu, Yale, Hu, Yuanliang, Liu, Jiaguo, Wang, Deyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042191/
https://www.ncbi.nlm.nih.gov/pubmed/27729787
http://dx.doi.org/10.2147/IJN.S115742
_version_ 1782456563833765888
author Zheng, Sisi
Luo, Li
Bo, Ruonan
Liu, Zhenguang
Xing, Jie
Niu, Yale
Hu, Yuanliang
Liu, Jiaguo
Wang, Deyun
author_facet Zheng, Sisi
Luo, Li
Bo, Ruonan
Liu, Zhenguang
Xing, Jie
Niu, Yale
Hu, Yuanliang
Liu, Jiaguo
Wang, Deyun
author_sort Zheng, Sisi
collection PubMed
description This study aimed to optimize the preparation conditions of pachyman (PHY)-loaded poly(d,l-lactic acid) (PLA) (PHYP) nanospheres by response surface methodology, explore their characteristics, and assess their effects on splenic lymphocytes. Double emulsion solvent evaporation was used to synthesize PHYP nanospheres, and the optimal preparation conditions were identified as a concentration of poloxamer 188 (F68) (w/v) of 0.33%, a concentration of PLA of 30 mg/mL, and a ratio of PLA to drug (w/w) of 10.25:1 required to reach the highest encapsulation efficiency, which was calculated to be 59.10%. PHYP had a spherical shape with a smooth surface and uniform size and an evident effect of sustained release and relative stability. Splenic lymphocytes are crucial and multifunctional cells in the immune system, and their immunological properties could be enhanced significantly by PHYP treatment. This study confirmed that PHY encapsulated in PLA nanospheres had comparatively steady properties and exerted obvious immune enhancement.
format Online
Article
Text
id pubmed-5042191
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50421912016-10-11 Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study Zheng, Sisi Luo, Li Bo, Ruonan Liu, Zhenguang Xing, Jie Niu, Yale Hu, Yuanliang Liu, Jiaguo Wang, Deyun Int J Nanomedicine Original Research This study aimed to optimize the preparation conditions of pachyman (PHY)-loaded poly(d,l-lactic acid) (PLA) (PHYP) nanospheres by response surface methodology, explore their characteristics, and assess their effects on splenic lymphocytes. Double emulsion solvent evaporation was used to synthesize PHYP nanospheres, and the optimal preparation conditions were identified as a concentration of poloxamer 188 (F68) (w/v) of 0.33%, a concentration of PLA of 30 mg/mL, and a ratio of PLA to drug (w/w) of 10.25:1 required to reach the highest encapsulation efficiency, which was calculated to be 59.10%. PHYP had a spherical shape with a smooth surface and uniform size and an evident effect of sustained release and relative stability. Splenic lymphocytes are crucial and multifunctional cells in the immune system, and their immunological properties could be enhanced significantly by PHYP treatment. This study confirmed that PHY encapsulated in PLA nanospheres had comparatively steady properties and exerted obvious immune enhancement. Dove Medical Press 2016-09-23 /pmc/articles/PMC5042191/ /pubmed/27729787 http://dx.doi.org/10.2147/IJN.S115742 Text en © 2016 Zheng et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zheng, Sisi
Luo, Li
Bo, Ruonan
Liu, Zhenguang
Xing, Jie
Niu, Yale
Hu, Yuanliang
Liu, Jiaguo
Wang, Deyun
Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
title Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
title_full Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
title_fullStr Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
title_full_unstemmed Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
title_short Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
title_sort evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042191/
https://www.ncbi.nlm.nih.gov/pubmed/27729787
http://dx.doi.org/10.2147/IJN.S115742
work_keys_str_mv AT zhengsisi evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT luoli evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT boruonan evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT liuzhenguang evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT xingjie evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT niuyale evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT huyuanliang evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT liujiaguo evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy
AT wangdeyun evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy